Institutions / Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC

CIK 1822947 · Institution · as of Dec 31, 2025

Portfolio value

$63.00M

Positions

As of

Dec 31, 2025

Top holdings

Dec 31, 2025

Company	Class	Value	Shares	% of portfolio
Abivax SA	—	$9.44M	70,000	15.0%
Soleno Therapeutics, Inc.	—	$7.78M	168,029	12.3%
Atai Beckley NV	—	$7.01M	1,713,105	11.1%
Inventiva SA	—	$6.97M	1,500,000	11.1%
Minerva Neurosciences, Inc.	—	$6.66M	1,655,500	10.6%
Praxis Precision Medicines, Inc.	—	$5.86M	19,882	9.3%
Edgewise Therapeutics, Inc.	—	$4.84M	195,000	7.7%
Eupraxia Pharmaceuticals Inc.	—	$3.00M	397,895	4.8%
Ovid Therapeutics Inc.	—	$2.91M	1,785,000	4.6%
Taysha Gene Therapies, Inc.TSHA	Common Stock	$2.51M	457,132	4.0%
Solid Biosciences Inc.SLDB	Common Stock	$2.33M	413,625	3.7%
Whitehawk Therapeutics, Inc.WHWK	Common Stock	$1.98M	817,939	3.1%
ProMIS Neurosciences, Inc.	—	$1.70M	249,339	2.7%

Activity

Dec 31, 2025

InsidersInstitutions

This fund's 13F position changes — what it's buying and selling.

No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.